CLN5 and polycystic ovary syndrome: Future larger studies with this BMP panel, together with measures of BMD and bone strength, are needed to determine their utility as biomarkers for bone physiology in weight-stratified PCOS patients, and whether any of these BMPs may be of utility as bone fragility markers in PCOS.